Trial Profile
Efficacy of fingolimod in disease modifying therapies-naive patients versus patients who previously treated with interferon-1b or glatiramer acetate in multiple sclerosis population: A retrospective study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 May 2017
Price :
$35
*
At a glance
- Drugs Fingolimod (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 03 May 2017 New trial record
- 28 Apr 2017 Results presented at the 69th Annual Meeting of the American Academy of Neurology